April 6, 2026

Quadrise moves to make marine fuel switching easier to assess

Quadrise has launched a vessel-based comparison tool to help shipowners judge whether its marine fuels offer a practical commercial advantage...

Atrium Therapeutics, Inc. (RNA) Stock Analysis: Uncovering a Potential 86% Upside

Atrium Therapeutics, Inc. (NASDAQ: RNA) is making waves in the biotechnology sector as an emergent player in RNA-based therapies. With a focus on cardiomyopathies, the company..

Bausch + Lomb (BLCO) Stock Analysis: Eyeing an 11.96% Upside with Strategic Growth in Global Eye Health

Bausch + Lomb Corporation (NYSE: BLCO), a stalwart in the healthcare sector under the Medical Instruments & Supplies industry, has been crafting a significant presence in..

Krystal Biotech, Inc. (KRYS) Stock Analysis: A 20% Upside Potential Beckons Investors

Krystal Biotech, Inc. (NASDAQ: KRYS), a prominent player in the biotechnology sector, continues to capture investor interest with its impressive market capitalization of $7.63 billion. As..

BridgeBio Pharma, Inc. (BBIO): Analyst Consensus Sees 37.58% Upside Potential in Biotech Innovator

BridgeBio Pharma, Inc. (NASDAQ: BBIO) has emerged as a focal point for investors keen on the biotechnology sector, thanks to its dynamic approach to addressing genetic..

Prestige Consumer Healthcare (PBH) Stock Analysis: A 49.58% Upside Potential with Strong Buy Ratings

Prestige Consumer Healthcare Inc. (NYSE: PBH) stands out in the healthcare sector as a key player in the over-the-counter (OTC) health and personal care market. With..

Lantheus Holdings, Inc. (LNTH) Stock Analysis: Exploring a 20% Potential Upside for Investors

Lantheus Holdings, Inc. (NASDAQ: LNTH) stands as a prominent player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry. Based in Bedford,..

Alkermes plc (ALKS) Stock Analysis: Evaluating a 25% Potential Upside Amidst Market Challenges

Alkermes plc (NASDAQ: ALKS), the Dublin-based biopharmaceutical company, presents an intriguing investment opportunity within the healthcare sector, specifically in the specialty and generic drug manufacturing industry...

TG Therapeutics, Inc. (TGTX) Stock Analysis: Exploring a 32.5% Upside Potential in Biotech

TG Therapeutics, Inc. (NASDAQ: TGTX), a prominent player in the biotechnology sector, stands out as a compelling investment opportunity, particularly for those interested in healthcare innovations...

Legend Biotech Corporation (LEGN) Stock Analysis: Potential 198.94% Upside in the Booming Cell Therapy Market

Legend Biotech Corporation (NASDAQ: LEGN) presents a compelling opportunity for investors seeking exposure to the innovative field of biotechnology, particularly in the burgeoning cell therapy sector...

Halozyme Therapeutics, Inc. (HALO): Investor Outlook Reveals 31.63% Upside Potential in Biotech Sector

Halozyme Therapeutics, Inc. (NASDAQ: HALO), a prominent player in the biotechnology industry, is drawing attention from investors with its impressive valuation metrics and strategic partnerships. With..

iRhythm Holdings, Inc. (IRTC) Stock Analysis: Exploring an 81% Upside Potential

iRhythm Holdings, Inc. (NASDAQ: IRTC), a key player in the healthcare sector, is capturing investor attention with a compelling upside potential of 81.02%. Specializing in medical..

Integer Holdings Corporation (ITGR) Stock Analysis: Exploring a 7.37% Upside Potential Amidst Strong Buy Ratings

Integer Holdings Corporation (NYSE: ITGR), a prominent player in the healthcare sector, specifically within the medical devices industry, presents a compelling case for investors seeking growth..

Repligen Corporation (RGEN) Investor Outlook: Potential 58.62% Upside Sparks Interest

Repligen Corporation (NASDAQ: RGEN), a key player in the healthcare sector, specializes in developing and commercializing bioprocessing technologies that are indispensable for the life sciences industry...

Merit Medical Systems, Inc. (MMSI) Stock Analysis: Exploring a 50.66% Potential Upside

Merit Medical Systems, Inc. (NASDAQ: MMSI), a prominent player in the healthcare sector specializing in medical instruments and supplies, presents a compelling case for investors eyeing..

Oscar Health, Inc. (OSCR) Stock Analysis: Unpacking the 29% Potential Upside

Oscar Health, Inc. (NYSE: OSCR), a healthcare technology company, has been making waves in the healthcare plans industry with its innovative approach to health insurance. With..

BrightSpring Health Services, Inc. (BTSG) Investor Outlook: A 22% Upside Potential Amid Robust Revenue Growth

For investors seeking opportunities in the healthcare sector, BrightSpring Health Services, Inc. (BTSG) presents a compelling case. As a leading provider of home and community-based healthcare..

Sarepta Therapeutics, Inc. (SRPT): Stock Analysis Reveals Challenges Amidst Biotech Innovations

Sarepta Therapeutics, Inc. (NASDAQ: SRPT) stands as a prominent player within the biotechnology sector, focusing on the development of genetic therapeutic modalities targeting rare diseases. The..

West Pharmaceutical Services (WST) Stock Analysis: A Steady Healthcare Innovator with 24% Upside Potential

West Pharmaceutical Services, Inc. (NYSE: WST), a key player in the healthcare sector, specializing in medical instruments and supplies, presents an intriguing opportunity for investors seeking..

Jazz Pharmaceuticals plc (JAZZ) Stock Analysis: A Biotech Powerhouse with a 19.55% Potential Upside

Investors eyeing the biotechnology sector may find Jazz Pharmaceuticals plc (NASDAQ: JAZZ) a compelling opportunity, given its promising pipeline and a notable 19.55% potential upside. This..

Search

Funds

April 6, 2026

Quadrise moves to make marine fuel switching easier to assess

Quadrise has launched a vessel-based comparison tool to help shipowners judge whether its marine fuels offer a practical commercial advantage...
Search

Funds

April 6, 2026

FTSE 100

Funds